References
- Alaimo A, Gorojod RM and Kotler ML. (2011). The extrinsic and intrinsic apoptotic pathways are involved in manganese toxicity in rat astrocytoma C6 cells. Neurochemistry International. 59:297-308. https://doi.org/10.1016/j.neuint.2011.06.001
- Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J and Greenberg ME. (1999). Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor. Cell. 96:857-868. https://doi.org/10.1016/S0092-8674(00)80595-4
- Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, Lin Y, Tran H, Ross SE, Mostoslavsky R, Cohen HY, Hu LS, Cheng HL, Jedrychowski MP, Gygi SP, Sinclair DA, Alt FW and Greenberg ME. (2004). Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science. 303:2011-2015. https://doi.org/10.1126/science.1094637
- Chung HS, An HJ, Jeong HJ, Won JH, Hong SH and Kim HM. (2004). Water extract isolated from Chelidonium majus enhances nitric oxide and tumour necrosis factor-alpha production via nuclear factor-kappaB activation in mouse peritoneal macrophages. The Journal of Pharmacy and Pharmacology. 56:129-134. https://doi.org/10.1211/0022357022467
- Dhar SK and St Clair DK. (2012). Manganese superoxide dismutase regulation and cancer. Free Radical Biology & Medicine. 52:2209-2222. https://doi.org/10.1016/j.freeradbiomed.2012.03.009
- Dijkers PF, Medema RH, Pals C, Banerji L, Thomas NS, Lam EW, Burgering BM, Raaijmakers JA, Lammers JW, Koenderman L and Coffer PJ. (2000). Forkhead transcription factor FKHR-L1 modulates cytokine-dependent transcriptional regulation of p27(KIP1). Molecular and Cellular Biology. 20:9138-9148. https://doi.org/10.1128/MCB.20.24.9138-9148.2000
- Gilca M, Gaman L, Panait E, Stoian I and Atanasiu V. (2010). Chelidonium majus-an integrative review: Traditional knowledge versus modern findings. Forschende Komplementarmedizin. 17: 241-248. https://doi.org/10.1159/000321397
- Habermehl D, Kammerer B, Handrick R, Eldh T, Gruber C, Cordes N, Daniel PT, Plasswilm L, Bamberg M, Belka C and Jendrossek V. (2006). Proapoptotic activity of Ukrain is based on Chelidonium majus L. alkaloids and mediated via a mitochondrial death pathway. BMC Cancer. 6:14. https://doi.org/10.1186/1471-2407-6-14
- Hu MC, Lee DF, Xia W, Golfman LS, Ou-Yang F, Yang JY, Zou Y, Bao S, Hanada N, Saso H, Kobayashi R and Hung MC. (2004). IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell. 117:225-237. https://doi.org/10.1016/S0092-8674(04)00302-2
- Kim HS, Yeo EJ, Park SH, Park JI, Park SC, Shin JY, Kim MJ, Oh SJ, Won MH, Kang TC, Park JB, Kim J, Kim JI, Lee HY and Lee JY. (2005). p21WAF/CIP1/SDI1 is upregulated due to increased mRNA stability during hydroxyurea-induced senescence of human fibroblasts. Mechanisms of Aging and Development. 126:1255-1261. https://doi.org/10.1016/j.mad.2005.07.002
- Kops GJ, Dansen TB, Polderman PE, Saarloos I, Wirtz KW, Coffer PJ, Huang TT, Bos JL, Medema RH and Burgering BM. (2002). Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature. 419:316-321. https://doi.org/10.1038/nature01036
- Koriem KM, Arbid MS and Asaad GF. (2013). Chelidonium majus leaves methanol extract and its chelidonine alkaloid ingredient reduce cadmium-induced nephrotoxicity in rats. Journal of Natural Medicines. 67:159-167. https://doi.org/10.1007/s11418-012-0667-6
- Lehtinen MK, Yuan Z, Boag PR, Yang Y, Villen J, Becker EB, DiBacco S, de la Iglesia N, Gygi S, Blackwell TK and Bonni A. (2006). A conserved MST-FOXO signaling pathway mediates oxidative-stress responses and extends life span. Cell. 125:987-1001. https://doi.org/10.1016/j.cell.2006.03.046
- Meng F, Zuo G, Hao X, Wang G, Xiao H, Zhang J and Xu G. (2009). Antifungal activity of the benzo[c]phenanthridine alkaloids from Chelidonium majus Linn against resistant clinical yeast isolates. Journal of Ethnopharmacology. 125:494-496. https://doi.org/10.1016/j.jep.2009.07.029
- Nadova S, Miadokova E, Alfoldiova L, Kopaskova M, Hasplova K, Hudecova A, Vaculcikova D, Gregan F and Cipak L. (2008). Potential antioxidant activity, cytotoxic and apoptosis-inducing effects of Chelidonium majus L. extract on leukemia cells. Neuro Endocrinology Letters. 29:649-652.
- Noureini SK and Wink M. (2009). Transcriptional down regulation of hTERT and senescence induction in HepG2 cells by chelidonine. World Journal of Gastroenterology. 15:3603-3610. https://doi.org/10.3748/wjg.15.3603
- Park JE, Cuong TD, Hung TM, Lee I, Na M, Kim JC, Ryoo S, Lee JH, Choi JS, Woo MH and Min BS. (2011). Alkaloids from Chelidonium majus and their inhibitory effects on LPS-induced NO production in RAW264.7 cells. Bioorganic & Medicinal Chemistry Letters. 21:6960-6963. https://doi.org/10.1016/j.bmcl.2011.09.128
- Paul A, Bishayee K, Ghosh S, Mukherjee A, Sikdar S, Chakraborty D, Boujedaini N and Khuda-Bukhsh AR. (2012). Chelidonine isolated from ethanolic extract of Chelidonium majus promotes apoptosis in HeLa cells through p38-p53 and PI3K/AKT signalling pathways. Journal of Chinese Integrative Medicine. 10:1025-1038.
- Philchenkov A, Kaminskyy V, Zavelevich M and Stoika R. (2008). Apoptogenic activity of two benzophenanthridine alkaloids from Chelidonium majus L. does not correlate with their DNA damaging effects. Toxicology In Vitro. 22:287-295. https://doi.org/10.1016/j.tiv.2007.08.023
- Ray PD, Huang BW and Tsuji Y. (2012). Reactive oxygen species(ROS) homeostasis and redox regulation in cellular signaling. Cellular Signalling. 24:981-990. https://doi.org/10.1016/j.cellsig.2012.01.008
- Salih DA and Brunet A. (2008). FoxO transcription factors in the maintenance of cellular homeostasis during aging. Current Opinion In Cell Biology. 20:126-136. https://doi.org/10.1016/j.ceb.2008.02.005
- Song JY, Yang HO, Shim JY, Ji Yeon A, Han YS, Jung IS and Yun YS. (2003). Radiation protective effect of an extract from Chelidonium majus. International Journal of Hematology. 78:226-232. https://doi.org/10.1007/BF02983799
- Sunters A, Fernandez de Mattos S, Stahl M, Brosens JJ, Zoumpoulidou G, Saunders CA, Coffer PJ, Medema RH, Coombes RC and Lam EW. (2003). FoxO3a transcriptional regulation of Bim controls apoptosis in paclitaxel-treated breast cancer cell lines. The Journal of Biological Chemistry. 278:49795-49805. https://doi.org/10.1074/jbc.M309523200
- Tran H, Brunet A, Grenier JM, Datta SR, Fornace AJ, Jr DiStefano PS, Chiang LW and Greenberg ME. (2002). DNA repair pathway stimulated by the forkhead transcription factor FOXO3a through the Gadd45 protein. Science. 296:530-534. https://doi.org/10.1126/science.1068712
- van der Horst A and Burgering BM. (2007). Stressing the role of FoxO proteins in lifespan and disease. Nature Reviews. Molecular Cell Biology. 8:440-450.
- Yang JY, Zong CS, Xia W, Yamaguchi H, Ding Q, Xie X, Lang JY, Lai CC, Chang CJ, Huang WC, Huang H, Kuo HP, Lee DF, Li LY, Lien HC, Cheng X, Chang KJ, Hsiao CD, Tsai FJ, Tsai CH, Sahin AA, Muller WJ, Mills GB, Yu D, Hortobagyi GN and Hung MC. (2008). ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation. Nature Cell Biology. 10:138-148. https://doi.org/10.1038/ncb1676
- Zhao Y, Wang Y and Zhu WG. (2011). Applications of posttranslational modifications of FoxO family proteins in biological functions. Journal of Molecular Cell Biology. 3:276-282. https://doi.org/10.1093/jmcb/mjr013
Cited by
- Mechanism for Antioxidant Activity of Nardostachys chinensis root Extract vol.57, pp.1, 2014, https://doi.org/10.3839/jabc.2014.003
- FOXO3a Activation by oxyresveratrol ofMorus bombyciskoidzumi extract mediates antioxidant activity vol.20, pp.1, 2016, https://doi.org/10.1080/19768354.2016.1143030